Michael Ackermann, Director at Tarsus Pharmaceuticals, Inc. (TARS), sold 3,829 shares at $25.00 ($96K) on 2021-08-06, disclosed to the SEC on 2021-08-10.
Open-market sale of $96k TARS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.00 | 3,129 | $78K | 81.7% |
| 2 | $25.00 | 700 | $18K | 18.3% |
| Total | $25.00 avg | 3,829 | $96K | 100% |
| Filing → |
| TARS | SELL | 2021-11-03 | $300K | — | Filing → |
| TARS | SELL | 2021-10-14 | $267K | — | Filing → |
| TARS | SELL | 2021-10-12 | $5K | — | Filing → |